Last reviewed · How we verify
XRX-001 Inactivated yellow fever vaccine
XRX-001 Inactivated yellow fever vaccine is a Biologic drug developed by GE Healthcare. It is currently in Phase 1 development.
At a glance
| Generic name | XRX-001 Inactivated yellow fever vaccine |
|---|---|
| Sponsor | GE Healthcare |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- XRX-001 Inactivated yellow fever vaccine CI brief — competitive landscape report
- XRX-001 Inactivated yellow fever vaccine updates RSS · CI watch RSS
- GE Healthcare portfolio CI
Frequently asked questions about XRX-001 Inactivated yellow fever vaccine
What is XRX-001 Inactivated yellow fever vaccine?
XRX-001 Inactivated yellow fever vaccine is a Biologic drug developed by GE Healthcare.
Who makes XRX-001 Inactivated yellow fever vaccine?
XRX-001 Inactivated yellow fever vaccine is developed by GE Healthcare (see full GE Healthcare pipeline at /company/ge-healthcare).
What development phase is XRX-001 Inactivated yellow fever vaccine in?
XRX-001 Inactivated yellow fever vaccine is in Phase 1.